Recursion Pharmaceuticals

The year’s biggest biotech haul shows investors are still chasing the AI dream
Pharma Voice
Fri, 04/4/25 - 09:46 am
artificial intelligence
Insilico
Recursion Pharmaceuticals
Isomorphic Labs
AI deals are surging, and Recursion’s ongoing Exscientia merger points to a new world of integration
Pharma Voice
Fri, 02/28/25 - 11:05 am
Recursion Pharmaceuticals
Exscientia
artificial intelligence
M&A
3 Cutting-Edge Biotech Stocks That Are Riding the AI Wave Like None Other
Motley Fool
Fri, 07/21/23 - 11:38 am
Recursion Pharmaceuticals
NVIDIA
Ginkgo Bioworks
Schrödinger
artificial intelligence
Roche Signs Machine-Learning Neuroscience Deal With Recursion
Bloomberg
Tue, 12/7/21 - 10:53 am
Roche
Genentech
artificial intelligence
machine learnings
Recursion Pharmaceuticals
cancer
Neuroscience
Biotech listings shows few signs of cooling
EP Vantage
Fri, 07/2/21 - 10:53 am
biotech
IPOs
Lyell Immunopharma
Recursion Pharmaceuticals
Centessa Pharmaceuticals
Verve Therapeutics
Graphite Bio
Recursion, targeting cancer, rare disease midstage tests, sets terms for $306M IPO
Fierce Biotech
Tue, 04/13/21 - 10:24 am
Recursion Pharmaceuticals
IPOs
artificial intelligence
Recursion will take its AI platform public in latest IPO filing, while rare heart mutation biotech jumps on SPAC train
Endpoints
Tue, 03/23/21 - 10:31 am
Recursion Pharmaceuticals
IPOs
artificial intelligence
Billing itself as the first AI biotech to launch human trials, Recursion adds $121M C round
Endpoints
Mon, 07/15/19 - 10:08 am
artificial intelligence
Recursion Pharmaceuticals
Artificial Intelligence Gaining Ground in Drug Development
BioSpace
Mon, 02/11/19 - 10:00 am
CASP
machine learning
artificial intelligence
drug development
Merck
Takeda
Atomwise
Bayer
GSK
Google DeepMind
Recursion Pharmaceuticals
Startup Aims to Develop 100 Drugs in 10 Years
Drug Discovery and Development
Wed, 12/10/14 - 08:34 am
biotech
R&D
Recursion Pharmaceuticals